Richman Eric I's Form 4 filing
Gain Therapeutics, Inc. (GANX) · filed Aug 17, 2021
- Accession no.
- 0001104659-21-107121
- Filed
- Aug 17, 2021
- Trade date
- Aug 16, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001209191-22-025180 (Apr 21, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Richman Eric ICIK 0001313876 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | Common Stock | MOption exerciseAcquired | +4,922 | $7.87 | +$38,736.14 | 216,820 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.